QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
LON:IDH

Immunodiagnostic Systems (IDH) Share Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free IDH Stock Alerts
Compare
Today's Range
N/A
50-Day Range
378
▼
378
52-Week Range
N/A
Volume
N/A
Average Volume
14,539 shs
Market Capitalization
£108.80 million
P/E Ratio
290.77
Dividend Yield
0.50%
Price Target
N/A
Stock Analysis
Stock Analysis
IDH stock logo

About Immunodiagnostic Systems Stock (LON:IDH)

Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.

IDH Stock News Headlines

March 25, 2024 | markets.businessinsider.com
EQS-News: DATAGROUP Acquires ISC Innovative Systems Consulting AG
March 21, 2024 | msn.com
2025 Volkswagen ID.7 First Drive Review: Okay, I Get It Now
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 21, 2024 | msn.com
Volkswagen ID.4 Makes Debut In India, Set To Hit Roads Soon
August 8, 2023 | msn.com
Farewell, Fake IDs: Age Verification Gets an Upgrade
June 26, 2023 | msn.com
Revenues and profits rise at Immunodiagnostic Systems in year after £110m takeover
June 20, 2023 | lse.co.uk
IDH.L Regulatory News
June 9, 2023 | finanznachrichten.de
Immunohistochemistry (IHC) Market worth $4.7 billion | MarketsandMarkets
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
May 13, 2023 | forbes.com
10 Best Leave Management Systems In 2023
April 8, 2023 | marketwatch.com
2023-2029 Immunodiagnostic Equipment Market Share and Growth Opportunities | Report by Industry Experts
February 23, 2023 | forbes.com
Epic Systems
February 18, 2023 | marketwatch.com
Veterinary Immunodiagnostic Device Market Analysis Report 2023 Along with Statistics Figures, till 2029
See More Headlines
Receive IDH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunodiagnostic Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/20/2018
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Current Symbol
LON:IDH
CUSIP
N/A
CIK
N/A
Web
www.idsplc.com
Phone
+44-191-5190660
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
290.77
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
6.84
Current Ratio
5.40
Quick Ratio
3.87

Sales & Book Value

Annual Sales
£34.25 million
Price / Sales
3.18
Cash Flow
GBX 84 per share
Price / Cash Flow
4.50
Book Value
GBX 187.60 per share
Price / Book
2.01

Miscellaneous

Outstanding Shares
28,784,000
Free Float
N/A
Market Cap
£108.80 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jaap Stuut (Age 51)
    CEO & Director
    Comp: $284k
  • Mr. Paul J. Martin
    Group Fin. Director, Company Sec. & Director
  • Mr. Sander Perret Gentil
    Head of Marketing & Communications
  • Nicola Mitton
    Group HR Director
  • Mr. Ed Coombes (Age 50)
    Head Of Bus. Devel. - Instrumentation
  • Dr. Rudolf Schemer Ph.D. (Age 60)
    CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region

Key Competitors

View All Competitors

IDH Stock Analysis - Frequently Asked Questions

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) announced its quarterly earnings data on Wednesday, June, 20th. The company reported $5.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.60 by $3.10.

Is Immunodiagnostic Systems a good dividend stock?

Immunodiagnostic Systems (LON:IDH) pays an annual dividend of GBX 0.02 per share and currently has a dividend yield of 0.50%. The dividend payout ratio is 1.46%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for IDH.

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), iShares Biotechnology ETF (IBB), Redrow (RDW), Netflix (NFLX), Sysco (SYY), TP ICAP Group (TCAP), Telford Homes (TEF), WisdomTree U.S. Multifactor Fund (USMF), American Tower (AMT) and Advanced Medical Solutions Group (AMS).

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:IDH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative